home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Commercial Potential of Personalized Medicine

 
  April 20, 2006  
     
 
Jacob Fleming Conferences, Hotel Marriott, Brussels
14th & 15th June 2006


Personalized medicine encompasses much more than genetics. New technologies and achievements in science have brought us a whole new way of thinking in medicine. In this forum, you can learn from the most experienced companies how to explore this field of huge medical and commercial potential. Get the most useful information in valuable presentations, interactive panel discussions, and networking coffee breaks & cocktail reception.

Key topics:
Which pharmaceutical areas can benefit most from personalized medicine?
Moving from Pharmacogenetic Effect to Personalized Medicine
What is the role of molecular diagnostic/predictive markers in this field?
The commercial value of PGx - from internal decision making to improved market options

 
 
Organized by: Jacob Fleming Group
Invited Speakers: Giuseppe Colucci, Roche Molecular Systems-RIC
Medical Manager Scientific Affairs
Duncan McHale, Pfizer Global R & D
Senior Director and Head Molecular Profiling
Steffen Stürzebecher, Schering AG
Head of Global Pharmacogenomics, Global Preclinical Development
Wayne Rosenkrans, Personalized Medicine Coalition, Vice Chair AstraZeneca, Business Strategy Director, External Scientific Affairs, AstraZeneca
and many others...
 
Deadline for Abstracts: see dates
 
Registration: multiple bookings discount
E-mail: events@jacobfleming.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.